InMode Ltd. Ordinary Shares (INMD) Dividend History

Company News

• [Latest] Global Cosmetic Surgery Market Size/Share Worth USD 207.6 Billion by 2033 at a 11.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

  The global cosmetic surgery market is expected to grow from $67.2 billion in 2023 to $207.6 billion by 2033, at a CAGR of 11.7%. The market is driven by the growing acceptability and desire for less invasive treatments, with surgical procedures and the female segment holding the highest market share.

  GlobeNewswire Inc.

  Featured Companies: ESTA VERO ZBH
• InMode (INMD) Q3 2024 Earnings Call Transcript

  InMode reported Q3 2024 earnings, with revenue and guidance missing expectations due to macroeconomic headwinds and a slowdown in minimally invasive treatments. The company is optimistic about its new platforms, IgniteRF and OptimasMAX, and is making organizational changes to align its target market.

  The Motley Fool
• InMode: Facing A Myraid Of Headwinds

  InMode's business seems heavily reliant on economic conditions, beyond management's control. See why INMD stock is a Hold.

  Seeking Alpha
• InMode (INMD) Q1 2024 Earnings Call Transcript

  INMD earnings call for the period ending March 31, 2024.

  The Motley Fool
• TG Therapeutics (TGTX) Reports Q1 Loss, Tops Revenue Estimates

  TG Therapeutics (TGTX) delivered earnings and revenue surprises of -133.33% and 15.59%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

  Zacks Investment Research

  Featured Companies: TGTX